Semax/Selank Product Brief

Ready-to-Sell Research Product Sheet

1. Compound Overview

Semax/Selank is a combined research product containing two synthetic peptides: Semax, a fragment derived from adrenocorticotropic hormone (ACTH), and Selank, a synthetic analog of the naturally occurring tetrapeptide tuftsin.

This combination has been studied in research contexts exploring complementary roles in neuroprotective signaling, cognitive pathways, stress-response modulation, and neurotrophic regulation. Together, these peptides have attracted interest in neurological and cognitive research involving learning, memory formation, emotional regulation, and neuroimmune interactions.

2. Mechanism of Interest

Semax and Selank are studied for multiple complementary biological mechanisms:

Semax-related mechanisms:
• Modulation of brain-derived neurotrophic factor (BDNF) signaling
• Influence on neurotransmitter regulation pathways
• Potential neuroprotective signaling effects
• Interaction with dopaminergic and serotonergic pathways
• Support of neural plasticity signaling networks

Selank-related mechanisms:
• Modulation of neurotransmitter systems including GABA and serotonin pathways
• Influence on stress-response signaling networks
• Potential anxiolytic signaling pathways
• Interaction with neuroimmune regulatory mechanisms
• Support of neuroplasticity and cognitive signaling

3. Research Areas Being Explored

• Cognitive performance and memory research
• Anxiety and stress response studies
• Neuroprotection and brain health models
• Learning, memory, and emotional regulation pathways
• Neurotransmitter and neurotrophic signaling research
• Neuroimmune interaction studies
• Behavioral and neurological function research

4. Suggested Research Product Formats

• 5 mg Semax / 5 mg Selank lyophilized vial
• Combined dual-peptide research vial (10 mg total content)
• Intranasal research solution formats

5. Example Reconstitution Chart

Example mixing protocols commonly used in research contexts:

5 mg + 2 mL sterile water = 2.5 mg/mL concentration (each peptide component)
10 mg total vial + 2 mL sterile water = 5 mg/mL concentration
(when evenly reconstituted)

These concentrations allow flexible dilution for laboratory research environments.

6. Label Information for Vials

• Compound name: Semax/Selank
• Total amounts per vial (Semax 5 mg / Selank 5 mg)
• Lot / batch number
• Manufacturing date
• Storage instructions (2–8°C recommended)
• Research use only disclaimer

7. Market Positioning

Semax/Selank is commonly positioned in the cognitive and neuropeptide research category as a dual-peptide formulation.

It is frequently associated with research exploring:

• Cognitive performance and memory pathways
• Stress and anxiety signaling mechanisms
• Neuroprotective and neurotrophic signaling
• Neurotransmitter balance and regulation
• Neuroimmune and behavioral research models

8. Example Research Stack Categories

• Semax/Selank + Dihexa
• Semax/Selank + NAD+
• Semax/Selank + cognitive research peptides
• Semax/Selank + neurotrophic signaling compounds

9. Safety and Regulatory Notes

Semax and Selank are not approved by the FDA for general medical treatment in the United States and are commonly distributed as research compounds.

This document is intended for informational and research product description purposes only.